Harrell v. Boehringer Ingelheim Pharmaceuticals, Inc. et al
| Elaine Harrell |
| Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim Corporation, Boehringer Ingelheim U.S.A. Corporation, GlaxoSmithKline LLC, GlaxoSmithKline Holdings (Americas) Inc., Pfizer Inc, Sanofi-Aventis U.S. LLC, Sanofi U.S. Services Inc., Patheon Manufacturing Services LLC, Chattem Inc. and Schnuck Market, Inc. |
| 9:2021cv82174 |
| December 7, 2021 |
| US District Court for the Southern District of Florida |
| Robin L Rosenberg |
| Personal Inj. Prod. Liability |
| 28 U.S.C. § 1332 |
| Both |
Docket Report
RSS Track this Docket
This docket was last retrieved on December 16, 2021. A more recent docket listing may be available from PACER.
| Document Text |
|---|
Filing 41
ORDER OF CONSOLIDATION AND ADMINISTRATIVE CLOSE-OUT. Signed by Judge Robin L. Rosenberg on 12/16/2021. See attached document for full details. (mc)
|
| Filing 40 MDL Transfer In Case Receipt from Eastern District of Missouri. Case Number 4:21-cv-01119 with documents 1-37. Assigned FLSD Case Number 9:21-cv-82174-RLR Harrell v. Boehringer Ingelheim Pharmaceuticals, Inc. et al on 12/7/2021. Re: FLSD MDL Case Number 9:20-md-02924-RLR pursuant to Transfer Order dated 12/3/2021. Clerks Note: JPML notified (mc) |
| Filing 39 Clerks Notice of Judge Assignment to Judge Robin L. Rosenberg. (mc) |
| Filing 38 Case transferred in from Missouri Eastern; Case Number 4:21-cv-01119. Electronic file including transfer order and docket sheet received. .(mc). |
|
Filing 37
ORDER OF MDL TRANSFER to: Southern District of Florida. Case transferred via CM/ECF extraction. (DLB)
|
| Filing 36 TRANSFER ORDER (with Schedule A) regarding MDL No. 2924 IN RE: ZANTAC (RANITIDINE) PRODUCTS LIABILITY LITIGATION signed by Karen K. Caldwell, Chair. (DJO) |
|
Filing 35
ORDER: IT IS HEREBY ORDERED that Defendants' Motion to Stay all Proceedings Pending Transfer to Multidistrict Litigation (Doc. #4 ) is GRANTED. IT IS FURTHER ORDERED that all proceedings and deadlines in the above-captioned case are STAYED until 14 days after the Judicial Panel on Multidistrict Litigation determines whether to transfer this action to an MDL proceeding and completes any transfer of this action pursuant to 28 U.S.C. 1407. Signed by District Judge Sarah E. Pitlyk on 9/28/2021. (KEK)
|
|
Filing 34
Docket Text ORDER: Re: #33 MOTION for Leave to Appear Pro Hac Vice Ashley C. Keller. The Certificate of Good Standing was attached.(Filing fee $100 receipt number AMOEDC-8882571) by Plaintiff Elaine Harrell. (Attachments: # 1 Certificate of Good Standing)(Keller, Ashley) filed by Elaine Harrell ; ORDERED GRANTED. Signed by District Judge Sarah E. Pitlyk on 9/23/21. (ARL)
|
| Filing 33 MOTION for Leave to Appear Pro Hac Vice Ashley C. Keller. The Certificate of Good Standing was attached.(Filing fee $100 receipt number AMOEDC-8882571) by Plaintiff Elaine Harrell. (Attachments: #1 Certificate of Good Standing)(Keller, Ashley) |
| Filing 32 REPLY to Response to Motion re #4 MOTION to Stay all Proceedings Pending Transfer to Multidistrict Litigation filed by Defendants Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim USA Corporation, Chattem, Inc., GlaxoSmithKline Holdings (Americas) Inc., GlaxoSmithKline LLC, Pfizer Inc., Sanofi US Services, Inc., Sanofi-Aventis U.S. LLC. (Rankin, W.) |
| Filing 31 DISCLOSURE OF ORGANIZATIONAL INTERESTS CERTIFICATE by Defendant GlaxoSmithKline Holdings (Americas) Inc... (Shaw, Booker) |
| Filing 30 DISCLOSURE OF ORGANIZATIONAL INTERESTS CERTIFICATE by Defendant GlaxoSmithKline LLC.. (Shaw, Booker) |
| Filing 29 ENTRY of Appearance by Booker T. Shaw for Defendants GlaxoSmithKline Holdings (Americas) Inc., GlaxoSmithKline LLC. (Shaw, Booker) |
| Filing 28 DISCLOSURE OF ORGANIZATIONAL INTERESTS CERTIFICATE by Defendant Boehringer Ingelheim USA Corporation. Parent companies: Boehringer Ingelheim International GmbH, Subsidiaries: none, Publicly held company: none,. (Strauss, Bettina) |
| Filing 27 DISCLOSURE OF ORGANIZATIONAL INTERESTS CERTIFICATE by Defendant Boehringer Ingelheim Corporation. Parent companies: Boehringer Ingelheim USA Corporation, Subsidiaries: None, Publicly held company: None,. (Strauss, Bettina) |
| Filing 26 DISCLOSURE OF ORGANIZATIONAL INTERESTS CERTIFICATE by Defendant Boehringer Ingelheim Pharmaceuticals, Inc.. Parent companies: Boehringer Ingelheim USA Corporation; Boehringer Ingelheim Corporation, Subsidiaries: None, Publicly held company: None,. (Strauss, Bettina) |
| Filing 25 MEMORANDUM in Support of Motion re #24 MOTION to Dismiss Case Pursuant to F.R.C.P. 12(b)(6) filed by Defendants Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim USA Corporation, Chattem, Inc., GlaxoSmithKline Holdings (Americas) Inc., GlaxoSmithKline LLC, Pfizer Inc., Sanofi US Services, Inc., Sanofi-Aventis U.S. LLC. (Rankin, W.) |
| Filing 24 MOTION to Dismiss Case Pursuant to F.R.C.P. 12(b)(6) by Defendants Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim USA Corporation, Chattem, Inc., GlaxoSmithKline Holdings (Americas) Inc., GlaxoSmithKline LLC, Pfizer Inc., Sanofi US Services, Inc., Sanofi-Aventis U.S. LLC. (Rankin, W.) |
| Filing 22 MEMORANDUM in Opposition re #4 MOTION to Stay all Proceedings Pending Transfer to Multidistrict Litigation filed by Plaintiff Elaine Harrell. (Holland, Eric) |
| Filing 21 MEMORANDUM in Opposition re #15 Emergency MOTION for Extension of Time to File Response/Reply to Plaintiff's Complaint filed by Plaintiff Elaine Harrell. (Holland, Eric) |
| Filing 20 MEMORANDUM in Support of Motion re #19 Emergency MOTION to Remand Case to State Court filed by Plaintiff Elaine Harrell. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4)(Holland, Eric) |
| Filing 19 Emergency MOTION to Remand Case to State Court by Plaintiff Elaine Harrell. (Attachments: #1 Text of Proposed Order Granting Motion to Remand)(Holland, Eric) |
| Filing 18 DISCLOSURE OF ORGANIZATIONAL INTERESTS CERTIFICATE by Defendant Sanofi-Aventis U.S. LLC.. (Rankin, W.) |
| Filing 17 DISCLOSURE OF ORGANIZATIONAL INTERESTS CERTIFICATE by Defendant Sanofi US Services, Inc... (Rankin, W.) |
| Filing 16 DISCLOSURE OF ORGANIZATIONAL INTERESTS CERTIFICATE by Defendant Chattem, Inc... (Rankin, W.) |
| Filing 15 Emergency MOTION for Extension of Time to File Response/Reply to Plaintiff's Complaint by Defendants Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim USA Corporation. (Attachments: #1 Exhibit A - Proposed Order)(Strauss, Bettina) |
| Filing 14 RESPONSE to Motion re #9 MOTION to Expedite Briefing Schedule and Ruling on Plaintiff's Upcoming Motion to Remand filed by Defendants Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim USA Corporation. (Strauss, Bettina) |
| Filing 13 ENTRY of Appearance by Bettina J. Strauss for Defendants Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim USA Corporation. (Strauss, Bettina) |
| Filing 12 Electronic Notice re: Disclosure of Organizational Interests Certificate Pursuant to Local Rule 2.09, every non-governmental organizational party must file a Disclosure of Organizational Interests Certificate within ten (10) days of the party's first pleading or entry of appearance. Please complete and file the certificate as soon as possible # (moed-0001.pdf). Disclosure of Organizational Interests Certificate due by 9/25/2021. (KEK) |
| Filing 11 ENTRY of Appearance by Randall S. Crompton for Plaintiff Elaine Harrell. (Crompton, Randall) |
| Filing 10 MEMORANDUM in Support of Motion re #9 MOTION to Expedite Briefing Schedule and Ruling on Plaintiff's Upcoming Motion to Remand filed by Plaintiff Elaine Harrell. (Attachments: #1 Exhibit A)(Holland, Eric) |
| Filing 9 MOTION to Expedite Briefing Schedule and Ruling on Plaintiff's Upcoming Motion to Remand by Plaintiff Elaine Harrell. (Attachments: #1 Text of Proposed Order Granting Motion to Expedite Briefing Schedule on Motion to Remand)(Holland, Eric) |
| Filing 8 ENTRY of Appearance by Eric D. Holland for Plaintiff Elaine Harrell. (Holland, Eric) |
| Filing 7 DISCLOSURE OF ORGANIZATIONAL INTERESTS CERTIFICATE by Defendant Pfizer Inc... (Sullivan, Bart) |
| Filing 6 ENTRY of Appearance by Bart C. Sullivan for Defendant Pfizer Inc.. (Sullivan, Bart) |
| Filing 5 MEMORANDUM in Support of Motion re #4 MOTION to Stay all Proceedings Pending Transfer to Multidistrict Litigation filed by Defendants Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim USA Corporation, Chattem, Inc., GlaxoSmithKline Holdings (Americas) Inc., GlaxoSmithKline LLC, Pfizer Inc., Sanofi US Services, Inc., Sanofi-Aventis U.S. LLC. (Rankin, W.) |
| Filing 4 MOTION to Stay all Proceedings Pending Transfer to Multidistrict Litigation by Defendants Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim USA Corporation, Chattem, Inc., GlaxoSmithKline Holdings (Americas) Inc., GlaxoSmithKline LLC, Pfizer Inc., Sanofi US Services, Inc., Sanofi-Aventis U.S. LLC. (Rankin, W.) |
| Filing 3 Petition (Removal/Transfer) Received From: Circuit Court, City of St Louis, filed by Elaine Harrell.(BAK) |
| Case Opening Notification: All non-governmental organizational parties (corporations, limited liability companies, limited liability partnerships) must file Disclosure of Organizational Interests Certificate # (moed-0001.pdf). Judge Assigned: U.S. District Judge Sarah E. Pitlyk. (BAK) |
| Filing 23 Electronic Notice re: Disclosure of Organizational Interests Certificate to Defendants Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim USA Corporation, GlaxoSmithKline Holdings (Americas) Inc., GlaxoSmithKline LLC. Pursuant to Local Rule 2.09, every non-governmental organizational party must file a Disclosure of Organizational Interests Certificate within ten (10) days of the party's first pleading or entry of appearance. Please complete and file the certificate as soon as possible # (moed-0001.pdf). Disclosure of Organizational Interests Certificate due by 9/24/2021. (CBL) |
| Filing 2 NOTICE OF FILING NOTICE OF REMOVAL filed by Defendants Chattem, Inc., Sanofi US Services, Inc., Sanofi-Aventis U.S. LLC Sent To: Plaintiff (Rankin, W.) |
| Filing 1 NOTICE OF REMOVAL from Circuit Court City of St. Louis, State of Missouri, case number 2122-CC09044, with receipt number AMOEDC-8863460, in the amount of $402 Jury Demand,, filed by GlaxoSmithKline Holdings (Americas) Inc., Chattem, Inc., boehringer ingelheim corporation, Pfizer Inc., Sanofi US Services, Inc., Boehringer Ingelheim Pharmaceuticals, Inc., Sanofi-Aventis U.S. LLC, Boehringer Ingelheim USA Corporation, GlaxoSmithKline LLC. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Exhibit E, #6 Civil Cover Sheet, #7 Original Filing Form)(Rankin, W.) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Florida Southern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
